美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant

0.2424

-0.0919-27.49%

成交量：2,200.00

成交额：533.30

市值：690.11万

市盈率：-0.01

高：0.2424

开：0.2424

低：0.2424

收：0.3343

52周最高：0.8121

52周最低：0.0525

股本：2,846.86万

流通股本：2,846.86万

量比：1.26

换手率：0.01%

股息：- -

股息率：- -

每股收益(TTM):-20.7379

净资产收益率：-245.18%

总资产收益率：-71.71%

市净率：0.78

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究，拓展Cypath® Lung无创肺癌早筛检测的样本采集选项

bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法

bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资，定价符合纳斯达克市场规则

bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BIAFW/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BIAFW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","market":"US","secType":"STK","nameCN":"bioAffinity Technologies Equity Warrants Exp 23 June 2027 Warrant","latestPrice":0.24241,"timestamp":1773345600000,"preClose":0.3343,"halted":0,"volume":2200,"delay":0,"changeRate":-0.2748728686808256,"floatShares":28468614,"shares":28468614,"eps":-20.7379,"marketStatus":"未开盘","change":-0.09189,"latestTime":"03-12 16:00:00 EDT","open":0.24241,"high":0.24241,"low":0.24241,"amount":533.302,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-20.7379,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773388800000},"marketStatusCode":0,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.3343,"volumeRatio":1.257574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIAFW\",,,,,undefined,":{"symbol":"BIAFW","floatShares":28468614,"roa":"-71.71%","roe":"-245.18%","lyrEps":0,"volumeRatio":1.257574,"shares":28468614,"dividePrice":0,"high":0.24241,"amplitude":0,"preClose":0.3343,"low":0.24241,"week52Low":0.0525,"pbRate":"0.78","psRate":"1.02","week52High":0.8121,"institutionHeld":0,"latestPrice":0.24241,"eps":-20.7379,"divideRate":0,"volume":2200,"delay":0,"ttmEps":-20.7379,"open":0.24241,"prevYearClose":0.35,"prevWeekClose":0.2602,"prevMonthClose":0.28,"prevQuarterClose":0.35,"fiveDayClose":0.2602,"twentyDayClose":0.2644,"sixtyDayClose":0.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIAFW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"BIAFW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIAFW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIAFW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIAFW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186193545","title":"bioAffinity Technologies携手布鲁克陆军医疗中心启动验证研究，拓展Cypath® Lung无创肺癌早筛检测的样本采集选项","url":"https://stock-news.laohu8.com/highlight/detail?id=1186193545","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186193545?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 21:32","pubTimestamp":1772026320,"startTime":"0","endTime":"0","summary":"生物亲和技术公司（bioAffinity Technologies）宣布，将与布鲁克陆军医疗中心（Brooke Army Medical Center）合作开展一项验证研究，旨在扩大其Cypath® Lung无创早期肺癌检测技术的样本采集方式。此项研究将评估不同样本采集方案的有效性，以提升该检测技术的可及性和应用便利性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BIAFW","BK4139"],"gpt_icon":0},{"id":"1142229976","title":"bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1142229976","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142229976?lang=zh_cn&edition=fundamental","pubTime":"2025-10-16 20:01","pubTimestamp":1760616074,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布获得美国专利申请的允许通知，涉及其肺癌诊断算法和检测方法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF","BIAFW"],"gpt_icon":0},{"id":"1129857267","title":"bioAffinity Technologies, Inc.宣布完成约180万美元普通股注册直接融资，定价符合纳斯达克市场规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1129857267","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129857267?lang=zh_cn&edition=fundamental","pubTime":"2025-10-09 03:47","pubTimestamp":1759952838,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资，本次融资通过发行普通股实现，股票定价按照纳斯达克市场规则执行。\n此次融资采用按市价定价的方式进行，严格遵循纳斯达克交易所的相关规定和要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"gpt_icon":0},{"id":"1116292885","title":"bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1116292885","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116292885?lang=zh_cn&edition=fundamental","pubTime":"2025-09-17 20:16","pubTimestamp":1758111399,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies宣布进行1:30反向股票拆分，将于2025年9月19日开盘时生效","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAFW","BIAF","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}